CDK2 and psoriasis: Evidence suggests that CDK2 is involved in the expression of inflammatory mediators in the psoriatic epidermis and regulates the psoriatic epidermal cell cycle,[55] suggesting that modulating CDK2 is an effective strategy for treating psoriasis.[56] This information undoubtedly provides us insight into studying the control of monkeypox.